Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-15 07:42 am Purchase | 13G | PERASO INC PRSO | Iroquois Capital Management LLC | 2,260,950 9.99% | 2,260,950 (New Position) | View |
2024-02-14 2:31 pm Purchase | 13G | AYRO INC AYRO | Iroquois Capital Management LLC | 7,000,181 9.99% | 7,000,181 (New Position) | View |
2024-02-14 11:32 am Sale | 13G | SMITH MICRO SOFTWARE INC N SMSI | Iroquois Capital Management LLC | 2,903,374 5.3% | -2,034,702 (-41.20%) | View |
2024-02-14 11:27 am Purchase | 13G | MYMD PHARMACEUTICALS INC MYMD | Iroquois Capital Management LLC | 5,065,582 4.99% | 3,294,438 (+186.01%) | View |
2024-02-12 4:30 pm Purchase | 13G | CHARLIES HLDGS INC CHUC | Iroquois Capital Management LLC | 17,826,764 7.8% | 26 (+0.00%) | View |
2024-01-22 07:15 am Purchase | 13G | CLEARMIND MEDICINE INC CMND | Iroquois Capital Management LLC | 347,799 9.99% | 347,799 (New Position) | View |
2023-09-12 10:12 am Purchase | 13G | AYRO INC AYRO | Iroquois Capital Management LLC | 14,354,130 9.99% | 13,220,561 (+1166.28%) | View |
2023-06-28 08:06 am Purchase | 13G | SMITH MICRO SOFTWARE INC N SMSI | Iroquois Capital Management LLC | 4,938,076 9.99% | 2,238,876 (+82.95%) | View |
2023-06-16 5:22 pm Unchanged | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 2,280,000 4.99% | 0 (Unchanged) | View |
2023-05-12 4:22 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 2,280,000 7% | 890,131 (+64.04%) | View |
2023-02-14 07:44 am Sale | 13G | SAVERONE 2014 LTD ADS REPSTG O SVRE | Iroquois Capital Management LLC | 681,430 4.45% | -536,865 (-44.07%) | View |
2023-02-14 07:40 am Sale | 13G | MYMD PHARMACEUTICALS INC MYMD | Iroquois Capital Management LLC | 1,771,144 6.47% | -407,464 (-18.70%) | View |
2023-02-13 08:03 am Purchase | 13G | CHARLIES HLDGS INC CHUC | Iroquois Capital Management LLC | 17,826,738 8% | 2,975,352 (+20.03%) | View |
2022-08-15 5:38 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 1,389,869 6.7% | 12,400 (+0.90%) | View |
2022-07-15 07:46 am Purchase | 13G | SAVERONE 2014 LTD ADS REPSTG O SVRE | Iroquois Capital Management LLC | 1,218,295 5.37% | 1,218,295 (New Position) | View |
2022-07-11 5:11 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 1,377,469 6.6% | 118,678 (+9.43%) | View |
2022-06-23 3:40 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 1,258,791 6.7% | 210,145 (+20.04%) | View |
2022-02-23 7:34 pm Sale | 13G | AYRO INC AYRO | Iroquois Capital Management LLC | 1,133,569 4.99% | -533,098 (-31.99%) | View |
2022-02-23 4:48 pm Purchase | 13G | BLUE EARTH, INC. BBLU | Iroquois Capital Management LLC | 156,445 0.9% | 31,310 (+25.02%) | View |
2022-02-23 4:45 pm Purchase | 13G | MYMD PHARMACEUTICALS INC MYMD | Iroquois Capital Management LLC | 2,178,608 9.56% | 2,178,608 (New Position) | View |